B.Y. Yeap

6.4k citations

65 papers · 2.0k indexed · h-index 20

Impact in

Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations

Papers in ⓘ

Pulmonary and Respiratory Medicine 36
- Lung Cancer Treatments and Mutations 16
- Radiation Therapy and Dosimetry 7
- Brain Metastases and Treatment 6
Oncology 28
- Lung Cancer Research Studies 10

Co-authors: Margaret A. Shipp (2 shared papers)Bruce E. Johnson (3 shared papers)George P. Canellos (2 shared papers)Pasi A. Jänne (4 shared papers)Xiao‐Jun Zhao (2 shared papers)K Blake (3 shared papers)AS Freedman (3 shared papers)Tak Takvorian (3 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (22 papers)Journal of Clinical Oncology (17 papers)Bone Marrow Transplantation (3 papers)Journal of Thoracic Oncology (2 papers)ESMO Open (2 papers)
Partner nations: United States Canada Australia

In The Last Decade

B.Y. Yeap

62 papers receiving 1.9k citations

Peers

Countries citing papers authored by B.Y. Yeap

Since Specialization

Citations

This map shows the geographic impact of B.Y. Yeap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.Y. Yeap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.Y. Yeap more than expected).

Fields of papers citing papers by B.Y. Yeap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.Y. Yeap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.Y. Yeap. The network helps show where B.Y. Yeap may publish in the future.

Co-authors

The 25 scholars most cited alongside B.Y. Yeap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B.Y. Yeap Line = papers co-authored together B.Y. Yeap links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer Journal of Clinical Investigation ·J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu, Eugene Lifshits, Ana M. Borras, Christopher-Michael Gale, George N. Naumov, B.Y. Yeap, E. Jarrell, Jing Sun, Samuel Tracy, Xiao‐Jun Zhao, John V. Heymach, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Jänne	2006	374
2	Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. Journal of Clinical Oncology ·AS Freedman, Tak Takvorian, KC Anderson, Peter Mauch, S N Rabinowe, K Blake, B.Y. Yeap, Robert J. Soiffer, F Coral, Lara Heflin	1990	147
3	Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma Blood ·AS Freedman, Jerome Ritz, Donna Neuberg, KC Anderson, SN Rabinowe, P Mauch, Tak Takvorian, RJ Soiffer, K Blake, B.Y. Yeap	1991	139
4	Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients British Journal of Cancer ·Jussi Koivunen, J. Kim, J. Lee, Andrew M. Rogers, J O Park, Xiao‐Jun Zhao, Katsuhiko Naoki, Isamu Okamoto, Kazuhiko Nakagawa, B.Y. Yeap, Matthew Meyerson, Kwok‐Kin Wong, William G. Richards, David J. Sugarbaker, Bruce E. Johnson, Pasi A. Jänne	2008	124
5	Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. Journal of Clinical Oncology ·Jane C. Weeks, B.Y. Yeap, George P. Canellos, Margaret A. Shipp	1991	109
6	The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. Journal of Clinical Oncology ·Margaret A. Shipp, B.Y. Yeap, Donald P. Harrington, M M Klatt, G S Pinkus, M S Jochelson, D S Rosenthal, A T Skarin, G P Canellos	1990	108
7	Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol. Journal of Clinical Oncology ·A. Chang, B.Y. Yeap, Thomas P. Davis, Ronald H. Blum, R. G. Hahn, Om E. Khanna, Harry Fisher, J. Thomas Rosenthal, Robert S. Witte, Roger Schinella, D L Trump	1996	104
8	Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients Neuro-Oncology ·Shannon M. MacDonald, R. Sethi, Beverly Lavally, B.Y. Yeap, Karen J. Marcus, Paul A. Caruso, Margaret B. Pulsifer, Mary Huang, David H. Ebb, N.J. Tarbell, Torunn I. Yock	2013	103
9	Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer Annals of Oncology ·Alice T. Shaw, Anna M. Varghese, Benjamin Solomon, Daniel B. Costa, Silvia Novello, Mari Mino–Kenudson, Mark M. Awad, Jeffrey A. Engelman, Gregory J. Riely, Valentina Monica, B.Y. Yeap, Giorgio V. Scagliotti	2012	93
10	Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib The Pharmacogenomics Journal ·Geoffrey Liu, Sarada Gurubhagavatula, Wei Zhou, Z. Wang, B.Y. Yeap, Kofi Asomaning, Li Su, Rebecca S. Heist, Thomas J. Lynch, David C. Christiani	2007	85
11	Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma JNCI Journal of the National Cancer Institute ·Gavin J. Gordon, Liangliang Dong, B.Y. Yeap, William G. Richards, Jonathan N. Glickman, HR Edenfield, M. Mani, Richard B. Colquitt, G. Maulik, Branden Van Oss, David J. Sugarbaker, Raphael Bueno	2009	66
12	Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma The Journal of Pathology ·GJ Gordon, M. Mani, Lipi Mukhopadhyay, L Dong, HR Edenfield, Jn Glickman, B.Y. Yeap, Sugarbaker Dj, Raphael Bueno	2007	59
13	Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma The Journal of Pathology ·GJ Gordon, M. Mani, Lipi Mukhopadhyay, L Dong, B.Y. Yeap, Sugarbaker Dj, Raphael Bueno	2007	55
14	XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk Carcinogenesis ·Geoffrey Liu, Wei Zhou, B.Y. Yeap, Li Su, John C. Wain, John M. Poneros, Norman S. Nishioka, Timothy Lynch, David C. Christiani	2007	48
15	Megestrol and Tamoxifen in Patients With Advanced Endometrial Cancer American Journal of Clinical Oncology ·Kishan J. Pandya, B.Y. Yeap, Louis M. Weiner, James E. Krook, John K. Erban, Roger Schinella, Thomas E. Davis	2001	44
16	Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. Journal of Clinical Oncology ·M A Shipp, M M Klatt, B.Y. Yeap, Maxine S. Jochelson, Peter Mauch, David I. Rosenthal, Arthur T. Skarin, George P. Canellos	1989	41
17	Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation Bone Marrow Transplantation ·Richard L. Haspel, G. Kao, B.Y. Yeap, Corey Cutler, Robert J. Soiffer, Edwin P. Alyea, Vincent T. Ho, John Koreth, B Dey, Steven L. McAfee, Eyal C. Attar, Thomas R. Spitzer, Joseph H. Antin, Karen K. Ballen	2007	39
18	Late Complications Following Total-body Irradiation and Bone Marrow Rescue in Mice: Predominance of Glomerular Nephropathy and Hemolytic Anemia International Journal of Radiation Biology ·J. D. Down, Adrienne J. Berman, Michael J. Warhol, B.Y. Yeap, Peter Mauch	1990	32
19	Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls. Journal of Clinical Oncology ·Alice T. Shaw, B.Y. Yeap, Benjamin Solomon, Gregory J. Riely, A. John Iafrate, Geoffrey I. Shapiro, Daniel B. Costa, Mohit Butaney, S-H.I. Ou, Robert G. Maki, Y. Bang, Marileila Varella‐Garcia, Ravi Salgia, Keith D. Wilner, Kimary Kulig, Paulina Selaru, Yuan Tang, E.L. Kwak, J. W. Clark, D. Ross Camidge	2011	28
20	High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant Bone Marrow Transplantation ·Christine Colby, S Koziol, SL McAfee, B.Y. Yeap, TR Spitzer	2002	20

About B.Y. Yeap

B.Y. Yeap is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Pathology and Forensic Medicine and Surgery, having authored 65 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (10 papers), Lymphoma Diagnosis and Treatment (7 papers), Radiation Therapy and Dosimetry (7 papers), Brain Metastases and Treatment (6 papers), Glioma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Advanced Radiotherapy Techniques (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (595 citations), Pulmonary and Respiratory Medicine (1.0k citations), Oncology (805 citations), Genetics (295 citations) and Hematology (185 citations). B.Y. Yeap has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Margaret A. Shipp, Bruce E. Johnson, George P. Canellos, Pasi A. Jänne, Xiao‐Jun Zhao, K Blake, AS Freedman, Tak Takvorian, Jane C. Weeks and Peter Mauch. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Bone Marrow Transplantation, Journal of Thoracic Oncology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact